In 2017, Robert De Niro and I hosted a packed press conference at the National Press Club in Washington, DC. We offered a $100,000 reward to anyone who could point to such a study. A prestigious group of scientists, including UCLA Fielding School Emeritus Professor of Epidemiology and Statistics Dr. Sander Greenland, toxicologist and past director of the Environmental Toxicology Program at the National Institute of Environmental Health Sciences, Dr. George Lucier, and Dr. Bruce Lanphear of Simon Fraser University and British Columbia Children’s Hospital, agreed to judge the study. There were no takers.
In 2001, the Institute of Medicine recommended thimerosal’s removal from all pediatric vaccines. In accordance with the IOM recommendation, manufacturers removed thimerosal from childhood vaccines—Hib, hepatitis b, and DTP—except multi-dose flu vaccines in the United States beginning in 2001. Japan and the European governments had already dramatically reduced mercury levels in their vaccines as early as 1993.
The European and US bans left Pharma struggling to unload stocks and find new ways to monetize stranded assets—the hundreds of millions in production facilities committed to mercury-based vaccines. Bill Gates came to Pharma’s rescue. Gates helped pharmaceutical companies unload their thimerosal inventories by dumping them in developing countries. Merck, with the help of Bill Gates and GAVI, brokered a deal to donate (dump) 1 million doses of their thimerosal-containing Recombivax HB hepatitis B vaccine to the Millennium Vaccine Initiative to African countries. The White House hailed Gates’s corporate welfare initiative as an “unprecedented level of corporate support” in a press release issued March 3, 2000.32
Despite the discontinuance in Western nations, Bill Gates and WHO continue to use their power to force African children to submit to a battery of potentially dangerous mercury-laced pediatric vaccines. Strong evidence suggests that African boys with higher testosterone and chronic vitamin D deficiencies are far more vulnerable to vaccine and thimerosal injury than whites.33, 34 When it comes to pharma profits, dead and brain-damaged African babies are merely collateral damage.
In 2012, Dr. Fauci waxed philosophical when a reporter asked him to describe an example of one of his useful collaborations with Gates. Perhaps, he speculated, NIAID would work with Gates and GAVI on a project to remove thimerosal from African vaccines. “What is used now is thimerosal, which is frowned upon because of concerns of mercury. So Seth [Berkley, Gates’s GAVI Director] and I were talking about finding a preservative for these multi-dose vials without thimerosal so we no longer would have the baggage associated with it.”35 By “baggage,” he apparently meant the millions of neurologically injured African children.36 There is no evidence that this particular collaboration survived its stillbirth as a hypothetical reverie. Eight years later, Africans are still carrying that toxic baggage. It’s a crushing—often mortal—load.37
Lethal Malaria Vaccine Experiments
Malaria claims some 655,000 lives annually, mostly African children aged under five.38 In 2010, the Gates Foundation funded with $300 million a Phase III trial of GlaxoSmithKline’s experimental malaria vaccine Mosquirix39 in seven African countries, “aimed at young children because their immune system is still developing.”40 GlaxoSmithKline contributed $500 million, NIAID contributed tens of millions in a battery of grants. Lesser funders included USAID, CDC, and Wellcome Trust. Gates is heavily invested in GSK.41 Apparently suspecting the vaccine might be lethal, Gates’s team elected not to test it against a placebo. They used, instead, highly reactogenic meningitis and rabies vaccines that, themselves, were never tested against a placebo. The meningitis jab was famous for causing alarming numbers of injuries and deaths. The use of a reactogenic placebo—a so-called fauxcebo—is a deliberately fraudulent gimmick that unscrupulous vaccine companies deploy to mask injuries in the study cohort by purposefully inducing injuries among the placebo cohort. Clinical trials that omit true inert placebos marketing masquerading as science. Some 151 African infants died in the trial, and 1,048 of the 5,049 babies suffered serious adverse effects—in both control and study groups—including paralysis, seizure, and febrile convulsions.42
Eager to secure the WHO approval necessary to license GSK’s vaccine for global distribution, the Bill and Melinda Gates Foundation brushed aside the lethal outcomes of these experiments, declaring the trial a mild disappointment but vowing to press on with the project, casualties be damned. “The efficacy came back lower than we had hoped, but developing a vaccine against a parasite is a very hard thing to do. The trial is continuing, and we look forward to getting more data to help determine whether and how to deploy this vaccine.” He demonstrated his resolve by donating an additional $200 million43 to finance more defective GSK research.
Even with Gates’s generous grubstake, GSK’s crooked clinical trial researchers could only muster a feeble claim of 30 percent efficacy for their infanticidal jab.44 Undaunted, Gates rolled out Mosquirix in 2019 as the first malaria vaccine in sub-Saharan Africa. It turned out to be another “genocide-for-girls” project. According to the publication Science, “Mosquirix’s efficacy and durability are mediocre. Four doses offer only 30 percent protection against severe malaria, for no more than 4 years. . . . The biggest concerns, however, are about the vaccine’s safety.” BMJ’s associate editor, Dr. Peter Doshi, points out, “These were a rate of meningitis in those receiving Mosquirix 10 times that of those who did not, increased cerebral malaria cases, and a doubling in the risk of death (from any cause) in girls.” Dr. Doshi says WHO’s Malaria Vaccine Study represents a “serious breach of international ethical standards.”45 The demonstrated risk worried WHO so much that it retreated from its plan to roll out the vaccine across Africa, in favor of smaller pilot programs in Malawi, Ghana, and Kenya that will administer the vaccine to hundreds of thousands of children instead of the 100 million that BMGF had hoped for.46
Virologists and academics around the world kept mum about Gates’s Mosquirix deaths. Gates’s plump purse, his impeccable connections, his power over the virology cartel, and the weakness and needs of African governments once again insulated him from the consequences of all these dead children—with the exception of Dr. Doshi.
Lethal Meningitis Vaccine Experiments
In 2010, Gates funded a MenAfriVac campaign in sub-Saharan Africa. Gates operatives forcibly vaccinated thousands of African children against meningitis, causing approximately 50 of 500 vaccinated children to develop paralysis.47 Citing additional abuses, South African newspapers declared, “We are guinea pigs for the drug makers.”48 Professor Patrick Bond, a political economist who served in Nelson Mandela’s South African government, describes Gates’s unseemly business—philanthropic practices and the agenda of the Gates Foundation—as “ruthless and immoral.”49